Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Third Harmonic Bio
300 Technology Square, 8th Floor
Cambridge, MA 02139
https://thirdharmonicbio.com/

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor for treatment of severe allergy and inflammation. KIT is a cell surface receptor that acts as the master survival and functional regulator of mast cells, which are immune cells concentrated at the body's interfaces with the external environment and that act as the key mediator of the inflammation associated with allergic diseases.

Key Contact
Name
Natalie Holles
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/17/22 $105,000,000 Series B Ajax Health
Boxer Capital
BVF Partners
Commodore Capital
Deep Track Capital
General Atlantic
RA Capital Management
RTW Investments
undisclosed


Featured Reading